BioLife Solutions Inc. | Mutual Funds
Mutual Funds that own BioLife Solutions Inc.
Vanguard Total Stock Market Index Fund
256,941
1.7%
35,765
0%
07/31/2018
Vanguard Extended Market Index Fund
87,608
0.57%
14,868
0%
07/31/2018
Wells Fargo Advantage Traditional Small Cap Growth Fund
74,400
0.49%
0
1.44%
07/31/2018
Altair Smaller Companies Fund
66,598
0.44%
0
0.47%
02/28/2018
Candriam Equities B - Global Health Care
66,000
0.44%
66,000
0.46%
07/31/2018
Fidelity Spartan Extended Market Index Fund
44,462
0.28%
0
0%
07/31/2018
37,500
0.25%
0
0.97%
05/31/2018
AST T Rowe Price Growth Opportunities Portfolio
28,200
0.19%
3,400
0.05%
03/29/2018
AMG Managers Essex Small/Micro Cap Growth Fund
21,298
0.14%
288
1.75%
06/29/2018
Invesco All Cap Market Neutral Fund
17,702
0.12%
17,702
0.15%
06/29/2018
| Address |
3303 Monte Villa Parkway
Bothell Washington 98021
United States
|
|
Employees
|
- |
| Website |
http://www.biolifesolutions.com |
| Updated |
07/08/2019 |
| BioLife Solutions, Inc. engages in the development, manufacture, and marketing of portfolio of biopreservation tools for cells, tissues, and organs including proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media. Its products include CryoStor, BloodStor, HypoThermosol FRS, and Cell Thawing Media. The company was founded by Boris Rubinsky in 1998 and it is headquartered in Bothell, WA. |
